Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

Published:1986-01 Issue:1 Volume:21 Page:
ISSN:0340-7004
Container-title:Cancer Immunology Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Nishimura Takashi,Togashi Yuji,Goto Makiko,Yagi Hideki,Uchiyama Yasushi,Hashimoto Yoshiyuki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF00199371.pdf

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Checkpoints and beyond – Immunotherapy in colorectal cancer;Seminars in Cancer Biology;2019-04

2. Porous microspheres: Synthesis, characterisation and applications in pharmaceutical & medical fields;International Journal of Pharmaceutics;2018-09

3. Mechanism of Enhanced Hematopoietic Response by Soluble β-Glucan SCG in Cyclophosphamide-Treated Mice;Microbiology and Immunology;2006-09

4. A MODIFIED APPROACH TO THE ADOPTIVE IMMUNOTHERAPY OF WALKER-256 CARCINOSARCOMA WITH A COMBINATION OF ACTIVATED MACROPHAGES AND PHOTODYNAMIC THERAPY;LASER THERAPY;2006

5. Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy;Cancer Science;2003-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP